Phase III Trial of Autologous Activated Macrophages in Advanced Colorectal Cancer

By Eymard J.C.   Lopez M.   Cattan A.   Bouche O.   Adjizian J.C.   Bernard J.  

European Journal of Cancer, Vol. 32, Iss. 11, 1996-10 ,pp. : 1905-1911

Elsevier

Access to resources Recommend Favorite

Phase I/II trial of topotecan given as continuous infusion in combination with oxaliplatin in 5-FU-pretreated patients with colorectal cancer

By Hütter G.   Szélenyi H.   Deckert P.   Keilholz U.   Thiel E.  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 2, 2004-08 ,pp. : 178-184

Springer Publishing Company

Access to resources Recommend Favorite

Phase I/II trial of capecitabine, oxaliplatin, and irinotecan in combination with bevacizumab in first line treatment of metastatic colorectal cancer

By  

Cancer Medicine, Vol. 2045-7634, Iss. 10, 2015-10 ,pp. : 1505-1513

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Phase I-II Trial of Fixed-dose Carboplatin and Escalating Paclitaxel in Advanced Ovarian Cancer

By Bolis G.   Scarfone G.   Zanaboni F.   Villa A.   Presti M.   Melpignano M.   Ferraris C.   Tateo S.   Guarnerio P.   Gentile A.   Parazzini F.  

European Journal of Cancer, Vol. 33, Iss. 4, 1997-04 ,pp. : 592-595

Elsevier

Access to resources Recommend Favorite

Phase I/II Trial of Paclitaxel and Vinorelbine in Advanced Non-Small Cell Lung Cancer

By Grunberg Steven   Dugan Matthew   Greenblatt Marc   Ospina David   Valentine John  

Cancer Investigation, Vol. 23, Iss. 5, 2005-07 ,pp. : 392-398

Informa Healthcare

Access to resources Recommend Favorite